Literature DB >> 8914045

Hyperoxaluria with hyperglycoluria not due to alanine:glyoxylate aminotransferase defect: a novel type of primary hyperoxaluria.

K J Van Acker1, F J Eyskens, M F Espeel, R J Wanders, C Dekker, I O Kerckaert, F Roels.   

Abstract

Considering the clinical heterogeneity of primary hyperoxaluria type I (PH1) and the fact that in many instances this diagnosis was made without enzymatic and immunohistochemical investigation, other disturbances of oxalate metabolism than those presently known can be expected in PH1. Using a gaschromatographic/mass spectrometric method that allows quantification of these acids, hyperoxaluria and hyperglycoluria was found repeatedly in two unrelated patients. The hyperoxaluria was unresponsive to pyridoxine. There was no nephrocalcinosis or urolithiasis. In the liver biopsy normal AGT activity and normal localization of this enzyme in the peroxisome was found. In one patient abnormal Km and maximal activity and mozaicism of AGT were excluded. Hyperoxaluria and hyperglycoluria were also found in other family members, suggesting autosomal dominant transmission. Although the underlying defect leading to hyperoxaluria and hyperglycoluria could not be identified in these patients, it is probable that they represent a separate type of primary hyperoxaluria.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8914045     DOI: 10.1038/ki.1996.494

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  5 in total

Review 1.  Current approaches to the management of primary hyperoxaluria.

Authors:  P Cochat; O Basmaison
Journal:  Arch Dis Child       Date:  2000-06       Impact factor: 3.791

2.  Genetic analysis: a diagnostic tool for primary hyperoxaluria type 1.

Authors:  Christian von Schnakenburg; Gill Rumsby; Bernd Hoppe; Kay Latta; Markus Kemper
Journal:  Pediatr Nephrol       Date:  2003-04-05       Impact factor: 3.714

3.  Primary hyperoxaluria type III gene HOGA1 (formerly DHDPSL) as a possible risk factor for idiopathic calcium oxalate urolithiasis.

Authors:  Carla G Monico; Sandro Rossetti; Ruth Belostotsky; Andrea G Cogal; Regina M Herges; Barbara M Seide; Julie B Olson; Eric J Bergstrahl; Hugh J Williams; William E Haley; Yaacov Frishberg; Dawn S Milliner
Journal:  Clin J Am Soc Nephrol       Date:  2011-09       Impact factor: 8.237

4.  Phenotypic and functional analysis of human SLC26A6 variants in patients with familial hyperoxaluria and calcium oxalate nephrolithiasis.

Authors:  Carla G Monico; Adam Weinstein; Zhirong Jiang; Audrey L Rohlinger; Andrea G Cogal; Beth B Bjornson; Julie B Olson; Eric J Bergstralh; Dawn S Milliner; Peter S Aronson
Journal:  Am J Kidney Dis       Date:  2008-10-31       Impact factor: 8.860

5.  A United States survey on diagnosis, treatment, and outcome of primary hyperoxaluria.

Authors:  Bernd Hoppe; Craig B Langman
Journal:  Pediatr Nephrol       Date:  2003-08-15       Impact factor: 3.714

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.